Qualigen Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QLGN and other ETFs, options, and stocks.

About QLGN

Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS.

CEO

Kevin A. Richardson

CEOKevin A. Richardson

Employees

Employees4

Headquarters

Carlsbad, California

HeadquartersCarlsbad, California

Founded

2004

Founded2004

Employees

Employees4

QLGN Key Statistics

Market cap

2.86M

Market cap2.86M

Price-Earnings ratio

-0.07

Price-Earnings ratio-0.07

Dividend yield

—

Dividend yield—

Average volume

17.65K

Average volume17.65K

High today

$4.12

High today$4.12

Low today

$3.75

Low today$3.75

Open price

$3.97

Open price$3.97

Volume

37.97K

Volume37.97K

52 Week high

$29.44

52 Week high$29.44

52 Week low

$2.85

52 Week low$2.85

People also own

Based on the portfolios of people who own QLGN. This list is generated using Robinhood data, and it’s not a recommendation.